Israel Englander’s Kite Pharma, Inc. KITE Stock Holding History

Israel Englander’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-100,000	Closed	-$18M	–	4307
2017 Q3	$18M	Buy	+100,000	New	+$13.9M	0.03%	851
2016 Q4	–	Sell	-160,000	Closed	-$8.94M	–	3974
2016 Q3	$8.94M	Buy	+160,000	New	+$8.91M	0.02%	995
2016 Q2	–	Sell	-50,000	Closed	-$2.3M	–	3850
2016 Q1	$2.3M	Hold	50,000	–	–	0.01%	1702
2015 Q4	$3.08M	Buy	+50,000	New	+$3.52M	0.01%	1665

Israel Englander's KITE Position: Q4 2017 in Review

Israel Englander sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 34,394 shares — an estimated $6.18M sold.

Israel Englander first reported a position in KITE in Q2 2015 and held it in 5 quarters. The position peaked at $6.18M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Israel Englander reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Israel Englander sold 34,394 Kite Pharma, Inc. shares in Q4 2017, an estimated $6.18M.
Israel Englander first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 5 quarters.
Israel Englander's Kite Pharma, Inc. position peaked at $6.18M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.